Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
作者信息
Minami J, Ohno E, Furukata S, Ishimitsu T, Matsuoka H
出版信息
J Hum Hypertens. 2009 Oct;23(10):683-6. doi: 10.1038/jhh.2009.31. Epub 2009 Apr 16.
PMID:19369955
Abstract
摘要
相似文献
1
Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
J Hum Hypertens. 2009 Oct;23(10):683-6. doi: 10.1038/jhh.2009.31. Epub 2009 Apr 16.
2
Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Hypertens Res. 2007 Apr;30(4):307-13. doi: 10.1291/hypres.30.307.
3
Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
Acta Pharmacol Sin. 2003 Apr;24(4):337-41.
4
Aliskiren/valsartan (Valturna) for hypertension.
Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5.
5
[Risk oriented therapy of hypertension. Lowering blood pressure and risk].
MMW Fortschr Med. 2007 Nov 15;149(46):53.
6
[The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
Lakartidningen. 2004 Jul 22;101(30-31):2426-7.
7
[VALISH].
Nihon Rinsho. 2006 Aug;64 Suppl 6:454-8.
8
[Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
MMW Fortschr Med. 2006 Feb 2;148(5):48-9.
9
Modulation of 24-h blood pressure profiles: a new target for treatment?
J Hypertens. 2005 Oct;23(10):1799-801. doi: 10.1097/01.hjh.0000183121.69585.f1.
10
The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
Blood Press. 2009;18(5):240-1. doi: 10.3109/08037050903318769.
引用本文的文献
1
Renin Feedback Is an Independent Predictor of Outcome in HFpEF.
J Pers Med. 2021 May 3;11(5):370. doi: 10.3390/jpm11050370.
Zotero 插件